Search results
The Zacks Analyst Blog Highlights Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and...
Zacks via Yahoo Finance Canada· 2 weeks agoFor Immediate Release Chicago, IL – June 24, 2024 – Zacks.com announces the list of stocks featured...
Gilead Sciences prevails in US government lawsuit over HIV drug patents
Reuters via Yahoo Canada News· 1 year ago(Reuters) -A federal jury on Tuesday found that Gilead Sciences Inc did not infringe U.S. patents...
Senate Democrats just proposed $21 billion in new COVID-19 funding — here are 3 healthcare stocks...
MoneyWise via Yahoo News· 2 years agoThe healthcare sector received a lot of investor attention during the early days of the COVID-19...
Gilead, US square off in billion-dollar HIV drug patent trial
Reuters via Yahoo Canada News· 1 year agoGilead Sciences Inc is headed to trial in Delaware federal court this week to fight claims that it...
‘We Just Lost Two Years.’ How COVID-19 Disrupted the Fight Against HIV
Time via Yahoo Canada News· 2 years agoMedical director of Ward 86 at San Francisco General, Monica Gandhi, watches as patients get off the...
15 Best Drug Stocks To Invest In
Insider Monkey via Yahoo Finance Canada· 7 months agoIn this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its...
Gilead's (GILD) Veklury Gets CHMP Nod in Damaged Liver Patients
Zacks via Yahoo Finance Canada· 10 months agoGilead's (GILD) Veklury gets a positive CHMP opinion, recommending the use of the drug to treat...
Column: Moderna and Pfizer are jacking up the price of COVID vaccines. The government should stop...
LA Times via Yahoo Finance Canada· 1 year agoModerna and Pfizer have announced plans to quadruple the price of their COVID vaccines, putting them...
Britain's NICE recommends against NHS use of 5 COVID treatments as not cost-effective
Reuters via Yahoo Finance Canada· 2 years agoBritain’s agency that determines if medicines should be used in the National Health Service (NHS), has recommended stopping the use of five COVID-19 treatments, including Merck & Co's's antiviral ...
Gilead to buy CymaBay for $4.3 billion in bets on liver disease treatment
Reuters via Yahoo Finance Canada· 5 months ago(Reuters) -Gilead Sciences has agreed to buy CymaBay Therapeutics for $4.3 billion, gaining access...